Erratum to: Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics

After publication of this work [1], it has come to our attention that there is an error in the author list of the initial version of this manuscript; rather than Ernest J Lam, the second author of the manuscript should be listed as Ernest T Lam.

We publish this correction to update the author list with this information. The correct author list is as follows:

Gunjan D Hariani, Ernest T Lam, Tammy Havener, Pui-Yan Kwok, Howard L McLeod, Michael J Wagner and Alison A Motsinger-Reif

This error was introduced during the final production process and the editors of BMC Research Notes apologise for any inconvenience caused.

Affiliations

1. Bioinformatics Research Center, North Carolina State University, 307 Ricks Hall, 1 Lampe Dr, 27695, CB7566, Raleigh, NC, USA

   • Gunjan D Hariani
   •  & Alison A Motsinger-Reif

2. Department of Statistics, North Carolina State University, Raleigh, NC, USA

   • Alison A Motsinger-Reif

3. Cardiovascular Research Institute, UCSF School of Medicine, San Francisco, CA, USA

   • Ernest T Lam
   •  & Pui-Yan Kwok

4. Center for Institute of Pharmacogenomics and Individualized Therapy, UNC Chapel Hill, Chapel Hill, NC, USA

   • Tammy Havener
   • , Howard L McLeod
   •  & Michael J Wagner

5. Moffitt Cancer Center, Tampa, FL, USA

   • Howard L McLeod

Corresponding author

Correspondence to Alison A Motsinger-Reif.

The online version of the original article can be found at 10.1186/1756-0500-7-360

Reprints and Permissions